Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan
· Delayed Price · Currency is TWD 151.00
-1.50 (-0.98%)
Apr 29, 2026, 1:30 PM CST
Alar Pharmaceuticals Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | -79.68 | 18.17 | 382.62 | -19.87 | -64.23 | Upgrade
|
| Depreciation & Amortization | 4.87 | 3.88 | 3.35 | 3.21 | 3.36 | Upgrade
|
| Loss (Gain) From Sale of Investments | -9.78 | - | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 0.75 | 8.54 | - | - | - | Upgrade
|
| Stock-Based Compensation | - | 0.85 | - | - | - | Upgrade
|
| Other Operating Activities | -62.45 | -93.43 | -9.65 | -15.49 | -1.5 | Upgrade
|
| Change in Accounts Receivable | - | - | 0.84 | -0.84 | - | Upgrade
|
| Change in Accounts Payable | 16.04 | -14.65 | 18.38 | 0.31 | 0.49 | Upgrade
|
| Change in Unearned Revenue | - | - | 1.25 | - | - | Upgrade
|
| Change in Other Net Operating Assets | -40.76 | 1.38 | 6.79 | -0.26 | -1.6 | Upgrade
|
| Operating Cash Flow | -171.03 | -75.27 | 403.57 | -32.95 | -63.47 | Upgrade
|
| Capital Expenditures | -2.87 | -32.17 | -6.34 | -1.14 | -1.58 | Upgrade
|
| Investment in Securities | 555.65 | -867.93 | -125.66 | -30.87 | 22.67 | Upgrade
|
| Other Investing Activities | 55.17 | 60.5 | 13.82 | 2.17 | 1.42 | Upgrade
|
| Investing Cash Flow | 607.95 | -839.6 | -118.18 | -29.84 | 22.51 | Upgrade
|
| Long-Term Debt Repaid | -2.4 | -1.34 | -1.28 | -0.93 | -0.93 | Upgrade
|
| Net Debt Issued (Repaid) | -2.4 | -1.34 | -1.28 | -0.93 | -0.93 | Upgrade
|
| Issuance of Common Stock | - | 1,676 | - | - | - | Upgrade
|
| Common Dividends Paid | -16.7 | -100.2 | - | - | - | Upgrade
|
| Financing Cash Flow | -19.1 | 1,574 | -1.28 | -0.93 | -0.93 | Upgrade
|
| Foreign Exchange Rate Adjustments | -30.17 | 6.85 | - | - | - | Upgrade
|
| Net Cash Flow | 387.66 | 666.37 | 284.11 | -63.71 | -41.89 | Upgrade
|
| Free Cash Flow | -173.9 | -107.44 | 397.23 | -34.09 | -65.05 | Upgrade
|
| Free Cash Flow Margin | -6316.67% | -1846.95% | 84.65% | -4260.75% | - | Upgrade
|
| Free Cash Flow Per Share | -2.60 | -1.62 | 6.96 | -0.60 | -1.14 | Upgrade
|
| Cash Interest Paid | 0.08 | 0.03 | 0.06 | 0.02 | 0.02 | Upgrade
|
| Cash Income Tax Paid | 5.47 | 8.41 | 1.23 | 0.04 | - | Upgrade
|
| Levered Free Cash Flow | -132.49 | -92.19 | 311.67 | -28.45 | -35.15 | Upgrade
|
| Unlevered Free Cash Flow | -132.44 | -92.18 | 311.71 | -28.43 | -35.13 | Upgrade
|
| Change in Working Capital | -24.73 | -13.28 | 27.26 | -0.79 | -1.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.